References
1. Ding W, Su Z. Modern pediatric cardiac surgery. Shandong science & technology press, 2013:470—476.
2. Roguin A, Goldstein J, Bar O, et al. Brain and neck tumors among physicians performing interventional procedures. Am. J. Cardiol., 2013, 111: 1368-72.
3. Tanaka A, Suzuki Y, Suzuki N, et al. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? Intern. Med., 2011, 50: 673-7.
Zhu, Peng et al. “Clinical evaluation of percutaneous and intra-operative device closure of atrial septal defects under transesophageal echocardiographic guidance: one center experience and mid-term follow-up.” Journal of cardiothoracic surgery  vol. 15,1 20. 14 Jan. 2020
Ewert P, Berger F, Daehnert I, et al. Transcatheter Closure of Atrial Septal Defects Without Fluoroscopy: Feasibility of a New Method. Circulation, 2000, 101(8):847-849.
6. Seol Jae-Hee,Kim Ah-Young,Jung Se-Yong et al. Intracardiac Echocardiogram: Feasibility, Efficacy, and Safety for Guidance of Transcatheter Multiple Atrial Septal Defects Closure.[J] .J Clin Med, 2022, 11.
7. Sharfi MH, Al-Ata J, Al-Kouatli A, et al. Safety and efficacy of transcatheter closure of atrial septal defect type II under transthoracic echocardiographic guidance: A case control study. J Saudi Heart Assoc, 2019, 31: 2-8.
8. Lu H, Chen L, Zhang G, et al. Clinical evaluation of percutaneous atrial septal defect closer guided by transthoracic echocardiography and/ or transesophageal echocardiography. Journal of Central South University: Medical Sciences,2015,40(6):646-650. (in Chinese)
9. Snijder Roel J R,Renes Laura E,Swaans Martin J et al. Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia.[J] .J Interv Cardiol, 2020, 2020: 1462140.
10. Xie S, Fang J, Yang C, et al. Percutaneous trans-jugular vein closure of atrial septal defect with steerable introducer under echocardiographic guidance. J Thorac Dis. 2015,7(10):1850–1853.
11. Gao M, Li Z, Zhao Y, Wen P. Analysis of the therapeutic effect of transesophageal echocardiography-guided percutaneous device closure of atrial septal defects via the right internal jugular vein in children. Echocardiography. 2019,36(7):1357–1363.
12. Zhang D, Pan X, Li P, et al. Tram-jugular transcatheter closure of atrial septal defect solely under echocardiography guidance in infants. Natl Med J China, 2019,99(6):458-461.
13. Interventional treatment of common congenital heart diseases: the common view of Chinese medical experts. Part one: Interventional treatment of atrial septal defect Journal of Interventional Radiology 2011,20(1):3-9.
14. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235 (23):2506–9
15. Houeijeh A, Hascoët S, Bouvaist H, et al. Transcatheter closure of large atrial septal defects (ASDs) in symptomatic children with device/weight ratio≥1.5. Int. J. Cardiol., 2018, 267: 84-87.
16. Rao PS. Role of Echocardiography in the Diagnosis and Interventional Management of Atrial Septal Defects. Diagnostics (Basel). 2022 Jun 18;12(6):1494.
17. Villablanca PA, Briston DA, Rodés-Cabau J, et al. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int. J. Cardiol., 2017, 241: 149-155.
18. Butera G, Lovin N, Basile DP. How to deal with atrial septal defect closure from right internal jugular vein: Role of venous-arterial circuit for sizing and over-the-wire device implantation[J]. Catheter Cardiovasc Interv,2016,89(1):120-123.
19. Xing QS, Wu Q. Development of biodegradable occluders in device closure treatment for congenital heart defects Chin J Thorac Cardiovase Surg 2017, 33(6):380-384